646 - Clinical and microbiological outcomes of omadacycline for pulmonary Mycobacterium abscessus complex

Saturday, October 19, 2024

4:03 PM – 4:15 PM US PT

Location: 403 A

Presenting Author(s)

Mohammed Al Musawa, PharmD, BCIDP (he/him/his)

Postdoctoral fellow
Wayne State University
Detroit, Michigan, United States

Slides

Co-Author(s)

RV

Raaga Vemula, MD

University of Texas at Tyler
Tyler, Texas, United States
MM

Mehriban Mammadova, n/a

University of Texas Health Science Center
Houston, Texas, United States
CW

Carly Wadle, MPH

University of Texas Health Science Center
Tyler, Texas, United States
AM

Anahit Muscarella, PharmD, BCACP

Vanderbilt University Medical Center
Nashville, Tennessee, United States
CC

Christo Cimino, PharmD, BCPS, BCIDP

Clinical Pharmacy Specialist, Infectious Diseases
Vanderbilt University Medical Center
Nashville, Tennessee, United States
JZ

John Zeuli, PharmD

Mayo Clinic
Rochester, Minnesota, United States
Catessa A. Howard, PharmD, BCIDP (she/her/hers)

Lead Clinical Pharmacy Specialist - Antimicrobial Stewardship
West Virginia University Medicine
Morgantown, West Virginia, United States
SB

Saira Butt, MD

Assistant Professor of Clinical Medicine
Indiana University School of Medicine
Indianapolis, Indiana, United States
CM

Carlos Mejia-Chew, MD

Instructor in Medicine
Washington University in St Louis
St. Louis, Missouri, United States
Yasir Hamad, MD

Adjunct Assistant Professor of Medicine
Washington University
Herndon, VA, United States
AO

Aaron Ong, B.S.

Johns Hopkins University School of Medicine
Baltimore, Maryland, United States
KC

Keira A. Cohen, MD

Johns Hopkins University School of Medicine
Baltimore, Maryland, United States
Emily A. Kaip, PharmD

Clinical Pharmacist
University of California, San Francisco Medical Center
San Francisco, California, United States
MT

Maria G. Tupayachi-Ortiz, MD

Department of Medicine, Division of Pulmonary and Critical Care Medicine, Miller School of Medicine, University of Miami
Miami, Florida, United States
CF

Christina T. Fiske, MD, MPH

Associate Professor
Vanderbilt University Medical Center
Nashville, Tennessee, United States
CJ

Chloe Judd, MPH

Wayne State University
Detroit, Michigan, United States
KC

Kaylee E. Caniff, PharmD, BCIDP

Postdoctoral Research Fellow
Anti-Infective Research Lab, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University
Royal Oak, Michigan, United States
MR

Michael J. Rybak, PharmD, PhD, MPH

Professor
Eugene Applebaum College of Pharmacy and Health Sciences
Detroit, Michigan, United States

Disclosure(s):

Mohammed Al Musawa, PharmD, BCIDP: No financial relationships to disclose

Raaga Vemula, MD: No financial relationships to disclose

Mehriban Mammadova, n/a: No financial relationships to disclose

Carly Wadle, MPH: No financial relationships to disclose

Anahit Muscarella, PharmD, BCACP: No financial relationships to disclose

Christo Cimino, PharmD, BCPS, BCIDP: No financial relationships to disclose

John Zeuli, PharmD: No financial relationships to disclose

Catessa A. Howard, PharmD, BCIDP: No financial relationships to disclose

Saira Butt, MD: No financial relationships to disclose

Carlos Mejia-Chew, MD: No financial relationships to disclose

Yasir Hamad, MD: No financial relationships to disclose

Aaron Ong, B.S.: No financial relationships to disclose

Keira A. Cohen, MD: No financial relationships to disclose

Emily A. Kaip, PharmD: No financial relationships to disclose

Maria G. Tupayachi-Ortiz, MD: No financial relationships to disclose

Christina T. Fiske, MD, MPH: No financial relationships to disclose

Chloe Judd, MPH: No financial relationships to disclose

Kaylee E. Caniff, PharmD, BCIDP: T2Biosystems: Honoraria

Michael J. Rybak, PharmD, PhD, MPH: Abbvie, Melinta, Sionogi, Merck, T2Biosystems: Advisor/Consultant, Grant/Research Support, Speaker